Source: OECD, Paris
| Description | Direct Link | ||
|---|---|---|---|
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Australia |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Austria |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Belgium |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Canada |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Chile |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Czechia |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Denmark |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Estonia |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Finland |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: France |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Germany |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Greece |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Hungary |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Iceland |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Israel |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Italy |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Korea |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Latvia |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Lithuania |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Luxembourg |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Netherlands |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: New Zealand |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Norway |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Portugal |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovak Republic |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovenia |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Spain |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Sweden |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Türkiye |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: United Kingdom |
A | ||
|
Variable: Total pharmaceutical consumption: A-Alimentary tract and metabolism / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Non-OECD Economies: Croatia |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Austria |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Chile |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Czechia |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Denmark |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Estonia |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Finland |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Germany |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Greece |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Hungary |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Iceland |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Israel |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Italy |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Korea |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Lithuania |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Netherlands |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: New Zealand |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Norway |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Portugal |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovak Republic |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovenia |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Spain |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Sweden |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Türkiye |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: United Kingdom |
A | ||
|
Variable: Total pharmaceutical consumption: A02A-Antacids / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Non-OECD Economies: Croatia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Australia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Austria |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Belgium |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Canada |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Chile |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Costa Rica |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Czechia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Denmark |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Estonia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Finland |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: France |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Germany |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Greece |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Hungary |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Iceland |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Israel |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Italy |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Korea |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Latvia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Lithuania |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Luxembourg |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Netherlands |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: New Zealand |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Norway |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Portugal |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovak Republic |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Slovenia |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Spain |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Sweden |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Türkiye |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: United Kingdom |
A | ||
|
Variable: Total pharmaceutical consumption: A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Non-OECD Economies: Croatia |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Australia |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Austria |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Belgium |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Canada |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Chile |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Costa Rica |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Czechia |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Denmark |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Estonia |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Finland |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: France |
A | ||
|
Variable: Total pharmaceutical consumption: A10-Drugs used in diabetes / Measure: Defined daily dosage per 1 000 inhabitants per day / Country: Germany |
A |